Clinical features of chronic active myocarditis in patients with heart failure and reduced left ventricular ejection fraction

Back

ESC2025 Premium Access

Clinical features of chronic active myocarditis in patients with heart failure and reduced left ventricular ejection fraction

Session: Novel treatment approaches in heart failure and cardiomyopathies

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor M. Ruiz Cano (Bad Oeynhausen, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Maria J Ruiz Cano

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

0 follower

6 more presentations in this session

Impact of rhythm control in wild-type transthyretin cardiac amyloidosis and atrial fibrillation: a retrospective analysis

Speaker: Doctor J. Vogel (Essen, DE)

Apical sparing and clinical parameters in patients with histologically confirmed transthyretin amyloidosis

Speaker: Mr T. Krammer (Regensburg, DE)

Impact of GDMT implementation on albuminuria in HFrEF

Speaker: Doctor N. Panagiotides (Vienna, AT)

Impact of tafamidis on sleep-disordered breathing in transthyretin cardiomyopathy

Speaker: Miss Y. Ferrari Chen (Pisa, IT)

Effects of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and an eGFR below 30 ml/min/1.73 m2

Speaker: Ms J. Locatelli Bet (Rio Do Sul, BR)

Access the full session

Novel treatment approaches in heart failure and cardiomyopathies

Speakers: Doctor M. Ruiz Cano, Doctor J. Vogel, Mr T. Krammer, Doctor N. Panagiotides, Miss Y. Ferrari Chen...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources